Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harrison D Winters

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Case Reports in Oncological Medicine|December 13, 2019
Tiptoeing on Metastatic Adenocarcinoma of the LungArupreet Kochar, Harrison D Winters, Li Zhang, et al.
Nature|November 4, 2016
Break-induced telomere synthesis underlies alternative telomere maintenanceRobert L Dilley, Priyanka Verma, Nam Woo Cho, et al.
Molecules (Basel, Switzerland)|December 23, 2020
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor ResponseAladdin Riad, Sarah B Gitto, Hwan Lee, et al.
Cancer Research|June 5, 2016
A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor TherapyMehran Makvandi, Kuiying Xu, Brian P Lieberman, et al.
Plos One|November 20, 2014
Host, pathogen, and environmental characteristics predict white-nose syndrome mortality in captive little brown myotis (Myotis lucifugus)Joseph S Johnson, DeeAnn M Reeder, James W McMichael, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Case Reports in Oncological Medicine|December 13, 2019
Tiptoeing on Metastatic Adenocarcinoma of the LungArupreet Kochar, Harrison D Winters, Li Zhang, et al.
Nature|November 4, 2016
Break-induced telomere synthesis underlies alternative telomere maintenanceRobert L Dilley, Priyanka Verma, Nam Woo Cho, et al.
Molecules (Basel, Switzerland)|December 23, 2020
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor ResponseAladdin Riad, Sarah B Gitto, Hwan Lee, et al.
Cancer Research|June 5, 2016
A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor TherapyMehran Makvandi, Kuiying Xu, Brian P Lieberman, et al.
Plos One|November 20, 2014
Host, pathogen, and environmental characteristics predict white-nose syndrome mortality in captive little brown myotis (Myotis lucifugus)Joseph S Johnson, DeeAnn M Reeder, James W McMichael, et al.
Pageof 1